Kennedy Keith reported option exercise involving 52,422 derivative units of CareDx, Inc. at $0.00 for $0 on Nov 5, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
CFO & COO
CFO & COO
Filed Nov 9, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
52,422Employee Stock Option (right to buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
48,229Direct
Trade date
Nov 5, 2026Option exercise
Filed
Nov 9, 2026, 6:26 PM ET4-day reporting delay
Accession
0001543503-26-000008Code M · Transaction 396414
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 5, 2026Option exercise52,422$29.43$1,542,779.46Trade 396405
Nov 5, 2026Sell28,256$76.55−$2,162,954.42Trade 396406
Nov 5, 2026Sell12,380$77.42−$958,439.79Trade 396407
Nov 5, 2026Sell6,897$78.59−$542,017.99Trade 396408
Nov 5, 2026Sell7,415$79.49−$589,383.50Trade 396409
Nov 5, 2026Sell3,403$80.38−$273,527.35Trade 396410
Nov 5, 2026Sell2,710$81.40−$220,605.11Trade 396411
Nov 5, 2026Sell300$82.08−$24,623.01Trade 396412
Nov 5, 2026Sell600$83.60−$50,160Trade 396413
10 transaction rows in this filing. Joint filers share the same rows.

CDNA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CDNA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 16, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −24%1w ago −15%1d ago +1.7%
Returns since7d30d90d180d1y

Footnotes in full

F1: The transaction reported in this row was effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 6, 2026. F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.00 to $76.99 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.00 to $77.99 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.00 to $78.97 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.00 to $79.95 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.00 to $80.95 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F7: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.00 to $81.94 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.07 to $82.08 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F9: 1/4th of the shares subject to this option shall vest on September 12, 2025 and 1/48th of the shares subject to the option shall vest monthly thereafter through September 30, 2028.